At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 36 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vitamin D Supplementation in Polycystic Ovary Syndrome: a Randomized Controlled Trial.
In Brief
A Phase 2 clinical trial evaluating Vitamin D and Placebo for Polycystic Ovary Syndrome. Completed, enrolled 36 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if vitamin D will improve insulin resistance, inflammation, and overall well-being in women with PCOS.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Ovary Syndrome
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2009
First PostedMay 2009
Primary CompletionFeb 2014
Study CompletionSep 2014
TodayJul 2026
First PostedMay 22, 2009
Enrollment StartMay 1, 2009
Primary CompletionFeb 1, 2014
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 17.1 years ago
Interventions
Vitamin Ddietary
Vitamin D 300 mcg by mouth once daily for 12 weeks
Placebodrug
Placebo by mouth once daily for 12 weeks